Skip to main content
. 2017 Jun 3;8(34):57889–57897. doi: 10.18632/oncotarget.18361

Table 1. Mutations detected in the patient and their functional implication status.

Disease relevant gene Alteration identified Possible functional implication a
KRAS G13D Yes
TET2 K95fs*18, N439fs*4 Yes
BRCA2 K1691fs*15 Yes
CEBPA H24fs*84 Yes
CTNNB1 S45F Yes
FBXW7 L234fs*5 Yes
TP53 P222L Yes
ARID1A P224fs*8 Yes
ASXL1 G645fs*12 Yes
CDH1 A634fs*29 Yes
MLH1 V612fs*2 Yes
NOTCH2 S1419fs*8 Yes
ALK E310D No
ARID2 R1679Q No
ATR P315T No
BARD1 P358_S364del No
CTNNA1 R540H No
ESR1 R269C No
FGFR3 K403fs*93 No
IL7R I121fs*1 No
IRF4 K302E No
IRS2 N21del, P1225L No
JAK1 P861fs*4 No
JAK2 V984M No
KDM6A R621C No
MLL2 P565L No
MYC G301D No
MYCN P237L No
NF1 R1870W No
NOTCH1 H196R No
NTRK3 M452V No
PIK3CG L91M No
PIK3R1 I292N, K593E No
PTCH1 E44del No
RB1 R910Q No
RUNX1T1 R336H No
SETD2 L2486M No
SPEN I2469V, P255del No
TGFBR2 T230M No

a Functional implication status was reported as part of the patient's genomic profile from Foundation Medicine.